Astragaloside IIICAS# 84687-42-3 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 84687-42-3 | SDF | Download SDF |
| PubChem ID | 441905 | Appearance | White powder |
| Formula | C41H68O14 | M.Wt | 784.97 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in methan | ||
| SMILES | CC1(C(CCC23C1C(CC4C2(C3)CCC5(C4(CC(C5C6(CCC(O6)C(C)(C)O)C)O)C)C)O)OC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)CO)O)O)O)C | ||
| Standard InChIKey | FVFSMBDVZVUETN-BQAOMNQWSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Astragaloside III has anti-gastric ulcer effects, and exhibits strong growth-promoting effects in cultured GES-1 cells. Astragaloside III can effectively reduce cancer cell survival in vitro and inhibit the tumor growth in vivo, the potential mechanism is the induction of cell apoptosis signaling pathways, suggests that it provides a new therapeutic tool to treat breast cancer. |
| In vitro | Effects of cycloartane saponins from hairy roots of Astragalus membranaceus Bge., on human tumor cell targets.[Pubmed: 20060881]Fitoterapia. 2010 Jul;81(5):447-51.For the first time three different natural compounds, isolated from hairy roots of Astragalus membranaceus, cultivated in airlift bioreactor were tested for their cytotoxic potential and apoptosis induction in a panel of human tumor cell lines. |
| In vivo | Astragaloside III from Astragalus membranaceus antagonizes breast cancer growth[Reference: WebLink]Afr. J. Tradit. Complem., 2015, 12(3):183-6.Astragaloside III has been used to treat different cancers; however their effect on breast cancer remains unknown. |
| Structure Identification | J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:43-51.Component analysis and structure identification of active substances for anti-gastric ulcer effects in Radix Astragali by liquid chromatography and tandem mass spectrometry.[Pubmed: 24780704 ]This study provided a comprehensive component analysis and structure identification of active substances for the anti-gastric ulcer effects of Radix Astragali. |
Astragaloside III Dilution Calculator
Astragaloside III Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.2739 mL | 6.3697 mL | 12.7393 mL | 25.4787 mL | 31.8484 mL |
| 5 mM | 0.2548 mL | 1.2739 mL | 2.5479 mL | 5.0957 mL | 6.3697 mL |
| 10 mM | 0.1274 mL | 0.637 mL | 1.2739 mL | 2.5479 mL | 3.1848 mL |
| 50 mM | 0.0255 mL | 0.1274 mL | 0.2548 mL | 0.5096 mL | 0.637 mL |
| 100 mM | 0.0127 mL | 0.0637 mL | 0.1274 mL | 0.2548 mL | 0.3185 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Astragaloside III is a natural product isolated from Astragalus.
References:
[1]. SHI Jing-chao, et al. Determination of Astragaloside Ⅲ and Astragaloside IV in Astragalus with HPLC-ELSD Method. World Journal of Integrated Traditional and Western Medicine, 2014-07
- Astragaloside I
Catalog No.:BCN5961
CAS No.:84680-75-1
- 3-O-(2'E,4'Z-Decadienoyl)ingenol
Catalog No.:BCN3767
CAS No.:84680-59-1
- Enalaprilat Dihydrate
Catalog No.:BCC5009
CAS No.:84680-54-6
- Astragaloside II
Catalog No.:BCN5962
CAS No.:84676-89-1
- Isoastragaloside I
Catalog No.:BCN2979
CAS No.:84676-88-0
- Lorcaserin HCl
Catalog No.:BCC5041
CAS No.:846589-98-8
- Decinnamoyltaxinine J
Catalog No.:BCN7210
CAS No.:84652-33-5
- Tea polyphenol
Catalog No.:BCN8518
CAS No.:84650-60-2
- 4-Nitrobenzyl dimethylcarbamate
Catalog No.:BCN3284
CAS No.:84640-31-3
- Eurycomanone
Catalog No.:BCN2990
CAS No.:84633-29-4
- Itraconazole
Catalog No.:BCC4914
CAS No.:84625-61-6
- H-Lys(Fmoc)-OH
Catalog No.:BCC2984
CAS No.:84624-28-2
- Astragaloside IV
Catalog No.:BCN5960
CAS No.:84687-43-4
- Arglabin
Catalog No.:BCC5299
CAS No.:84692-91-1
- UVI 3003
Catalog No.:BCC7638
CAS No.:847239-17-2
- Calceolarioside A
Catalog No.:BCN5347
CAS No.:84744-28-5
- Qingyangshengenin
Catalog No.:BCN4389
CAS No.:84745-94-8
- Eriocalyxin B
Catalog No.:BCN4390
CAS No.:84745-95-9
- CEP-18770
Catalog No.:BCC2093
CAS No.:847499-27-8
- SHA 68
Catalog No.:BCC6210
CAS No.:847553-89-3
- NVP-BEP800
Catalog No.:BCC2129
CAS No.:847559-80-2
- ICG 001
Catalog No.:BCC3632
CAS No.:847591-62-2
- Tasumatrol L
Catalog No.:BCN6955
CAS No.:847835-17-0
- S 32212 hydrochloride
Catalog No.:BCC6208
CAS No.:847871-78-7
Component analysis and structure identification of active substances for anti-gastric ulcer effects in Radix Astragali by liquid chromatography and tandem mass spectrometry.[Pubmed:24780704]
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jun 1;960:43-51.
This study provided a comprehensive component analysis and structure identification of active substances for the anti-gastric ulcer effects of Radix Astragali. The data were generated by organically combining the results from in vivo pharmacodynamic experiments, a cell growth-promoting assay, structure identification, content determination, fingerprinting, and correlation analyses. The fingerprints from high-performance liquid chromatography coupled with a diode array detector (HPLC-DAD) and from HPLC coupled with evaporative light scattering detectors (ELSD) from 95% ethanol extracts of Radix Astragali (ERA) were determined using HPLC-DAD-ELSD. The structures of 16 compounds were identified using ultra-pressure liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS). The contents of these 16 compounds were simultaneously determined in a single run using HPLC-DAD-ELSD. The strength of the anti-ulceration effect of each of the 16 compounds was correlated to its content in the HPLC spectrum using gray relation statistics. The sequence of the contribution from each of the 16 compounds to the anti-gastric ulcer effect was determined. The results showed that ononin, astragalosideIII, and astragalosideIV contributed most to the observed anti-gastric ulcer effects and that these three compounds also exhibited strong growth-promoting effects in cultured GES-1 cells. The results of this study can be used to evaluate the quality of Radix Astragali and to provide a theoretical foundation for its further study.
Effects of cycloartane saponins from hairy roots of Astragalus membranaceus Bge., on human tumor cell targets.[Pubmed:20060881]
Fitoterapia. 2010 Jul;81(5):447-51.
For the first time three different natural compounds, isolated from hairy roots of Astragalus membranaceus, cultivated in airlift bioreactor were tested for their cytotoxic potential and apoptosis induction in a panel of human tumor cell lines. Root cultures, cultivated in bioreactor gave 18.5 g l(-1) dry wt roots with the highest astragaloside production in vitro up to now - 1.64% (astragaloside I), 1.12% (astragaloside II) and 1.08% (Astragaloside III). In this manner the production in airlift bioreactor can be used as means of reliable supply of cycloartane saponins to extend the research to human clinical studies.
